Title:
DIARYL MACROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION, AND USE THEREOF
Document Type and Number:
Japanese Patent JP2022126780
Kind Code:
A
Abstract:
To provide a novel compound that has excellent tyrosine kinase inhibitory activity, or a pharmaceutically acceptable salt, solvate, active metabolite, polymorph, isotope label, isomer or prodrug thereof.SOLUTION: The present invention provides a compound represented by formula (1), or a pharmaceutically acceptable salt, solvate, active metabolite, polymorph, isotope label, isomer or prodrug thereof.SELECTED DRAWING: None
More Like This:
Inventors:
ZHU LI
WU WEI
YANG YANQING
HE WEI
WU WEI
YANG YANQING
HE WEI
Application Number:
JP2022100260A
Publication Date:
August 30, 2022
Filing Date:
June 22, 2022
Export Citation:
Assignee:
PRIMEGENE BEIJING CO LTD
International Classes:
C07D515/18; A61K31/519; A61P25/00; A61P25/04; A61P29/00; A61P35/00; A61P37/06; A61P43/00; C07D498/18; C07D498/22
Domestic Patent References:
JP2013530142A | 2013-07-25 | |||
JP2017503867A | 2017-02-02 | |||
JP7128345B2 | 2022-08-30 |
Attorney, Agent or Firm:
Patent Attorney Corporation Okada International Patent Office